A recent publication (24 August 2016) by Munyua et al., shows that the ranked priority disease list for Kenya having emphasis towards Neglected Tropical Diseases, with the top five being (Anthrax, Trypanosomiasis, Rabies, Brucellosis, and Rift Valley Fever). read more
A recent (16 August 2016) publication by Arnold et al. tries to dymistify "the possible role of wildlife in the dissemination of AMR, specifically how wildlife might acquire and transport AMR and the potential for them to transmit AMR to humans and livestock." The...
1.1 Introductory statement This blog post will initially provide an overview of the achievements and “pending issues” of the Millennium Development Goals (MDGs) and the opportunities that the Sustainable Development Goals (SDGs) present to the East African Community...
Records at the Kenya national Foot-and-Mouth Disease Laboratory show that previous studies on FMD in Kenya have mainly focused on cattle and rarely on other susceptible domestic species (Wekesa et al., 2014) and only to a minor extent on wildlife. However, in 1979, a field survey isolated SAT1 and SAT2 FMDVs from buffalo populations in the southern part of Kenya (Anderson et al., 1979). read more
This blog entry will try and elucidate the shift in investment from infectious to non-communicable diseases by the World Health Organisation (WHO) drawing successes from the Millennium Development Goals 6: “To combat HIV/AIDS, malaria, and other diseases”. Initially this blog entry will provide an overview of the management strategies and progress that has been made in addressing infectious diseases (using the “big three diseases” of the MDG 6 as examples). It will then highlight the financial investment from the different Global Health Actors towards these ‘big 3 diseases’ as compared to the other diseases and in conclusion determine if the WHO shift in investment is justifiable or not. read more
There is evidence that MRSA infection increases the risk of mortality, morbidity, medical care costs and loss of productivity. The increased medical care costs accrued directly as expenses caused by extension of hospital stay, additional diagnostic or therapeutic procedures, and additional antibiotic use while loss of productivity is due to absence from work during hospitalization. At the same time, published data concerning the antibiotic susceptibility patterns of MRSA in sub-Saharan Africa are extremely limited, and few studies on it have been conducted in Kenya . Many studies on MRSA in Kenya are mainly cross-sectional with a focus to determine the prevalence, identifying the antibiotic resistance but they have not focused on the zoonotic significance of MRSA. There is need to understand on how the resistance to MRSA is changing over time so as to be able to clearly visualize the mechanism and transfer of resistance genes in the population . read more
Peter Daszak, President Ecohealth Alliance, in this short video reiterates on how Ebola was a wake up call for them and that their research at the Ecohealth alliance has shown that emergence of disease is a result of anthropogenic actions of man to the environment. read more
Cysticercosis is prevalent in several parts of the world. It is endemic and one of the leading causes of acquired epilepsy in developing countries, mainly in parts of Asia, Africa, Latin America and Eastern Europe. This is especially in those areas with uncontrolled free range pig production, poor sanitation and where humans and animals live in close contact. Its incidence is also increasing in developed countries as a result of migration of infected persons and frequent travel to and from endemic areas.
In man, cysticercosis frequently involves many parts of the body including the brain (causing fatal neurocysticercosis), subcutaneous tissues, heart, liver, lungs, peritoneum, skeletal muscles and the eye. Although oral involvement by cysticercosis is common in swine, this location is a very rare occurrence in humans where it presents as a component of disseminated cysticercosis and often a diagnostic challenge to clinicians . read more
Brucellosis is the most common and widespread of all bacterial zoonotic infections affecting man, livestock and wild animals (OIE., 2012; Corbel., 2006 and FAO., 2003) with significant socio-economic impacts and human suffering in endemic areas (Young., 1995; Boschiroli et al., 2001; McDermott., 2013). In Kenya, the nationwide prevalence of brucellosis in animals is unknown (ZDU., 2015) but the Zoonotic Disease Unit (ZDU) is in the process of determining the national prevalence and incidence through the current and ongoing study at Kajiado county in Kenya. Previous work by ZDU on brucellosis has been published on June this year 2015 as, "Sero-prevalence of Brucellosis in Humans and their Animals: A Linked Cross-sectional Study in Two Selected Counties in Kenya" read more
Since there is no blueprint for making 'One Health‘ operational, I agree with the Atlanta Report by Normandeau (2011) that the alternative is to have a 'One Health Global Guidance Group'-G3 that will provide neutrality, credibility and built on the existing international, regional and sub-national platforms for interaction and outreach such as EcoHealth, so as to find practicable approaches that factor in the needs of all "actors" in developed and developing worlds. read more